Researchers examine the potential contribution of Chlamydia pneumoniae and SARS-CoV-2 infections to Alzheimer’s disease pathogenesis, focusing on neuroinflammatory mechanisms and genetic factors such as APOEε4.
A new study identified human pegivirus in the brains and blood of patients with Parkinson’s disease, revealing virus-linked immune and gene expression changes that varied by genetic background.
Gabapentin use was associated with a 29% increased risk of dementia and an 85% increased risk of mild cognitive impairment within 10 years of pain diagnosis.
Researchers find that hearing aids and cochlear implants improve social quality of life and reduce perceived social handicap in adults with hearing loss.
A study of over 24,000 patients identified four common diagnostic paths that lead to Alzheimer’s disease, with multi-step sequences posing higher risk than single conditions and showing reproducibility in a national validation cohort.
A sweeping 30-year review confirms the Mediterranean-style diet lowers risks of heart disease, diabetes, cancer, and cognitive decline—while supporting global sustainability.
Newborns have higher levels of phosphorylated tau217 in their blood than even patients with Alzheimer’s disease, a new study finds, raising new questions about the dual role of tau in brain development and degeneration.
Once used for coughs, ambroxol is being investigated for Parkinson disease dementia. A new trial shows it is safe and biologically active, though cognitive benefits remain unproven.